Bruker Corp (BRKR)
80.59
-1.61
(-1.96%)
USD |
NASDAQ |
Apr 25, 16:00
80.54
-0.05
(-0.06%)
After-Hours: 20:00
Bruker Price to Book Value: 8.056 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 8.056 |
| April 24, 2024 | 8.217 |
| April 23, 2024 | 8.243 |
| April 22, 2024 | 7.802 |
| April 19, 2024 | 7.773 |
| April 18, 2024 | 7.853 |
| April 17, 2024 | 8.291 |
| April 16, 2024 | 8.386 |
| April 15, 2024 | 8.572 |
| April 12, 2024 | 8.755 |
| April 11, 2024 | 9.025 |
| April 10, 2024 | 8.850 |
| April 09, 2024 | 8.999 |
| April 08, 2024 | 9.020 |
| April 05, 2024 | 9.039 |
| April 04, 2024 | 8.974 |
| April 03, 2024 | 9.097 |
| April 02, 2024 | 9.088 |
| April 01, 2024 | 9.290 |
| March 28, 2024 | 9.391 |
| March 27, 2024 | 9.383 |
| March 26, 2024 | 9.237 |
| March 25, 2024 | 9.304 |
| March 22, 2024 | 9.387 |
| March 21, 2024 | 9.424 |
| Date | Value |
|---|---|
| March 20, 2024 | 9.294 |
| March 19, 2024 | 9.197 |
| March 18, 2024 | 9.199 |
| March 15, 2024 | 9.207 |
| March 14, 2024 | 9.180 |
| March 13, 2024 | 9.257 |
| March 12, 2024 | 9.269 |
| March 11, 2024 | 9.153 |
| March 08, 2024 | 9.113 |
| March 07, 2024 | 9.216 |
| March 06, 2024 | 9.050 |
| March 05, 2024 | 9.014 |
| March 04, 2024 | 9.002 |
| March 01, 2024 | 8.830 |
| February 29, 2024 | 8.651 |
| February 28, 2024 | 8.645 |
| February 27, 2024 | 8.367 |
| February 26, 2024 | 8.357 |
| February 23, 2024 | 8.925 |
| February 22, 2024 | 8.827 |
| February 21, 2024 | 8.635 |
| February 20, 2024 | 8.548 |
| February 16, 2024 | 8.624 |
| February 15, 2024 | 8.443 |
| February 14, 2024 | 8.438 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.316
Minimum
Apr 01 2020
13.77
Maximum
Sep 03 2021
8.931
Average
8.904
Median
Dec 13 2019
Price to Book Value Benchmarks
| Azenta Inc | 1.175 |
| Harvard Bioscience Inc | 2.114 |
| Bionano Genomics Inc | 0.4776 |
| Akoya Biosciences Inc | 3.491 |
| Singular Genomics Systems Inc | 0.1637 |
Price to Book Value Related Metrics
| PE Ratio | 27.60 |
| PS Ratio | 4.002 |
| PEG Ratio | 0.5906 |
| Price to Free Cash Flow | 48.79 |
| Price | 80.59 |
| Earnings Yield | 3.62% |
| Market Cap | 11.09B |
| PEGY Ratio | 0.5874 |
| Operating PE Ratio | 24.54 |
| Normalized PE Ratio | 32.54 |